Bernd Merkl

GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany.

Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany.